Paris, Ile-de-France, France In 2008 was created Fonds Stratu00e9gique d'Investissement, which is appeared as VC. The fund was located in Europe if to be more exact in France. The main department of described VC is located in the Paris.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Fonds Stratu00e9gique d'Investissement, startups are often financed by Idinvest Partners, Vertex Ventures Israel, Vertex Ventures. The meaningful sponsors for the fund in investment in the same round are Idinvest Partners, Visa, Vertex Ventures Israel. In the next rounds fund is usually obtained by Long Arc Capital, Jolt Capital, Bpifrance.
The overall number of key employees were 4.
The fund is constantly included in less than 2 deals per year. This Fonds Stratu00e9gique d'Investissement works on 21 percentage points more the average amount of lead investments comparing to the other organizations. Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2010. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2015.
Besides, a startup needs to be aged 11-15 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the various public portfolio startups of the fund, we may underline Viadeo, Tinubu Square, Cylande Among the most popular fund investment industries, there are Industrial Manufacturing, Security. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Abionyx Pharma | $59M | 25 Jul 2010 | Balma, Midi-Pyrenees, France | ||
Dailymotion | $25M | 23 Oct 2009 | France, Ile-de-France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Abionyx Pharma | $59M | 25 Jul 2010 | Balma, Midi-Pyrenees, France | ||
Dailymotion | $25M | 23 Oct 2009 | France, Ile-de-France |
